No historical price data available
No price history data available for the selected time period.
Try selecting a different time range.
Company Overview
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Company Information
- CEO
- Daniel A. Carestio
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 18000
Contact Information
- Website
- https://www.steris.com
- Address
- 70 Sir John Rogerson's Quay
- Country
- IE
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 22.55B market capitalization
- Trading Volume: 408.06K shares traded today
- Price Range: 52-week range of $200.98 - $252.79
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for STERIS plc
STERIS plc (STE) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 22.55B, the company represents a significant player in its market. The stock is currently trading at $229.27 with a positivedaily change of 0.39%.
The company's 18000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 37.22, beta of 0.92, and 52-week price range from $200.98 to $252.79when evaluating investment opportunities.
Why Invest in STERIS plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Daniel A. Carestio
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential